<DOC>
	<DOC>NCT02869867</DOC>
	<brief_summary>Nursing study, prospective, randomized, two-center open-label. Patients will be randomized into two groups during their first laying Qutenza®: - Patients receiving the laying of Qutenza® without refrigerated cushion - Patients receiving the laying of Qutenza® associated with a refrigerated cushion The objective of the study is to evaluate the effectiveness of the application of cold to the reduction of pain (burning) after one hour of patch installation high concentration capsaicin (Qutenza®) in patients localized neuropathic pain.</brief_summary>
	<brief_title>Does the Application of Cold Decreases the Pain Associated in the Pose of a Patch of Capsaicine at High Concentration on the Carrier Patients of Localized Neuropathic Pains ? - DIDOCAP</brief_title>
	<detailed_description />
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Capsaicin</mesh_term>
	<criteria>Major Do not opposing the participation in the study Monitoring in the case of localized neuropathic pain Diagnostic with neuropathic pain score ≥ 4 Neuropathic pain conventional treatment failure of firstline Front advantage of laying a first patch Qutenza® With ability to understand the proposed study Patch Installation on the feet, face, mucous membranes Eutectic mixture of local anesthetics (EMLA) Pose premedication Having Already received prior to the installation of a patch of Qutenza® Allergy to components Qutenza® Known and poorly stabilized hypertension Known cryoglobulinaemia Pregnant or lactating women Patient enjoying a measure of legal protection (guardianship, guardianship ...) Private Patient freedom No affiliation to a social security scheme. Refusal to participate in the study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>